NCT06095752View on ClinicalTrials.gov

Multiple Myeloma Prognostic Indices

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Multiple MyelomaHematologic Diseases
Interventions
OTHER

blood viscosity , albumin / fibrinogen ratio and red cell distribution

In multiple myeloma patients ,we get blood viscosity , albumin / fibrinogen ratio and red cell distribution directly after confirmed diagnosis to determine the prognosis of the disease in association with these tests results

Trial Locations (1)

88

Assiut University hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER